Cargando…

A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer

OBJECTIVE: This study evaluates the feasibility and performance of careHPV, a novel human papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low-resource settings. METHODS AND MATERIALS: Clinician-collected (cervical) and self-collected (vaginal) careHPV specimens, v...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeronimo, Jose, Bansil, Pooja, Lim, Jeanette, Peck, Roger, Paul, Proma, Amador, Juan Jose, Mirembe, Florence, Byamugisha, Josaphat, Poli, Usha Rani, Satyanarayana, Labani, Asthana, Smita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047307/
https://www.ncbi.nlm.nih.gov/pubmed/24557438
http://dx.doi.org/10.1097/IGC.0000000000000084
_version_ 1782480390580076544
author Jeronimo, Jose
Bansil, Pooja
Lim, Jeanette
Peck, Roger
Paul, Proma
Amador, Juan Jose
Mirembe, Florence
Byamugisha, Josaphat
Poli, Usha Rani
Satyanarayana, Labani
Asthana, Smita
author_facet Jeronimo, Jose
Bansil, Pooja
Lim, Jeanette
Peck, Roger
Paul, Proma
Amador, Juan Jose
Mirembe, Florence
Byamugisha, Josaphat
Poli, Usha Rani
Satyanarayana, Labani
Asthana, Smita
author_sort Jeronimo, Jose
collection PubMed
description OBJECTIVE: This study evaluates the feasibility and performance of careHPV, a novel human papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low-resource settings. METHODS AND MATERIALS: Clinician-collected (cervical) and self-collected (vaginal) careHPV specimens, visual inspection with acetic acid (VIA), and Papanicolaou test were evaluated among 16,951 eligible women in India, Nicaragua, and Uganda. Women with positive screening results received colposcopy and histologic follow-up as indicated. The positivity of each screening method was calculated overall, by site, and age. In addition, the clinical performance of each screening test was determined for detection of cervical intraepithelial neoplasia (CIN) grade 2 (CIN2+) and CIN grade 3. RESULTS: Moderate or severe dysplasia or cancer (taken together as CIN2+) was diagnosed in 286 women. The positivity rate ranged between 2.4% to 19.6% for vaginal careHPV, 2.9% to 20.2% for cervical careHPV, 5.5% to 34.4% for VIA, and 2.8% to 51.8% for Papanicolaou test. Cervical careHPV was the most sensitive for CIN2+ (81.5%; 95% confidence interval [CI], 76.5–85.8) and CIN grade 3 (85.3%; 95% CI, 78.6–90.6) at all sites, followed by vaginal careHPV (69.6% and 71.3%, respectively). The sensitivity of VIA ranged from 21.9% to 73.6% and Papanicolaou test from 40.7% to 73.7%. The pooled specificities of cervical careHPV, vaginal careHPV, VIA, and Papanicolaou test were 91.6%, 90.6%, 84.2%, and 87.7%, respectively. CONCLUSIONS: careHPV performed well in large multicountry demonstration studies conducted in resource-limited settings that have not previously been conducted this type of testing; its sensitivity using cervical samples or vaginal self-collected samples was better than VIA or Papanicolaou test. The feasibility of using careHPV in self-collected vaginal samples opens the possibility of increasing coverage and early detection in resource-constrained areas.
format Online
Article
Text
id pubmed-4047307
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-40473072014-06-06 A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer Jeronimo, Jose Bansil, Pooja Lim, Jeanette Peck, Roger Paul, Proma Amador, Juan Jose Mirembe, Florence Byamugisha, Josaphat Poli, Usha Rani Satyanarayana, Labani Asthana, Smita Int J Gynecol Cancer Cervical Cancer OBJECTIVE: This study evaluates the feasibility and performance of careHPV, a novel human papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low-resource settings. METHODS AND MATERIALS: Clinician-collected (cervical) and self-collected (vaginal) careHPV specimens, visual inspection with acetic acid (VIA), and Papanicolaou test were evaluated among 16,951 eligible women in India, Nicaragua, and Uganda. Women with positive screening results received colposcopy and histologic follow-up as indicated. The positivity of each screening method was calculated overall, by site, and age. In addition, the clinical performance of each screening test was determined for detection of cervical intraepithelial neoplasia (CIN) grade 2 (CIN2+) and CIN grade 3. RESULTS: Moderate or severe dysplasia or cancer (taken together as CIN2+) was diagnosed in 286 women. The positivity rate ranged between 2.4% to 19.6% for vaginal careHPV, 2.9% to 20.2% for cervical careHPV, 5.5% to 34.4% for VIA, and 2.8% to 51.8% for Papanicolaou test. Cervical careHPV was the most sensitive for CIN2+ (81.5%; 95% confidence interval [CI], 76.5–85.8) and CIN grade 3 (85.3%; 95% CI, 78.6–90.6) at all sites, followed by vaginal careHPV (69.6% and 71.3%, respectively). The sensitivity of VIA ranged from 21.9% to 73.6% and Papanicolaou test from 40.7% to 73.7%. The pooled specificities of cervical careHPV, vaginal careHPV, VIA, and Papanicolaou test were 91.6%, 90.6%, 84.2%, and 87.7%, respectively. CONCLUSIONS: careHPV performed well in large multicountry demonstration studies conducted in resource-limited settings that have not previously been conducted this type of testing; its sensitivity using cervical samples or vaginal self-collected samples was better than VIA or Papanicolaou test. The feasibility of using careHPV in self-collected vaginal samples opens the possibility of increasing coverage and early detection in resource-constrained areas. Lippincott Williams & Wilkins 2014-03 2014-03-03 /pmc/articles/PMC4047307/ /pubmed/24557438 http://dx.doi.org/10.1097/IGC.0000000000000084 Text en Copyright © 2014 by IGCS and ESGO http://creativecommons.org/licenses/by-nc-nd/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Cervical Cancer
Jeronimo, Jose
Bansil, Pooja
Lim, Jeanette
Peck, Roger
Paul, Proma
Amador, Juan Jose
Mirembe, Florence
Byamugisha, Josaphat
Poli, Usha Rani
Satyanarayana, Labani
Asthana, Smita
A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer
title A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer
title_full A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer
title_fullStr A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer
title_full_unstemmed A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer
title_short A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer
title_sort multicountry evaluation of carehpv testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer
topic Cervical Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047307/
https://www.ncbi.nlm.nih.gov/pubmed/24557438
http://dx.doi.org/10.1097/IGC.0000000000000084
work_keys_str_mv AT jeronimojose amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT bansilpooja amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT limjeanette amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT peckroger amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT paulproma amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT amadorjuanjose amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT mirembeflorence amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT byamugishajosaphat amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT poliusharani amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT satyanarayanalabani amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT asthanasmita amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT jeronimojose multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT bansilpooja multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT limjeanette multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT peckroger multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT paulproma multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT amadorjuanjose multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT mirembeflorence multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT byamugishajosaphat multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT poliusharani multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT satyanarayanalabani multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT asthanasmita multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer
AT multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer